Global Neurodiagnostics Market Forecast up to 2025
- February, 2019
- Domain: Healthcare - Diagnostics
- Get Free 10% Customization in this Report
[110 pages report] This market research report identifies GE healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems Corporation, Hitachi Medical Corporation, and Nihon Kohden Corporation as the major vendors operating in the global neurodiagnostics market. This report also provides a detailed analysis of the market by technology [neuroimaging technologies (computed tomography (CT), nuclear medicine imaging (NMI), magnetic resonance imaging (MRI), electroencephalography (EEG), magnetoencephalography (MEG), near infrared spectroscopic imaging (NIRS) and voxel-based morphometry), in vitro diagnostics, and neuroinformatics] and by regions (North America, Europe, APAC and Rest of the World).
Overview of the Neurodiagnostics Market Research
Infoholic’s market research report predicts that the Global Neurodiagnostics Market will grow at a CAGR of 7.5% during the forecast period. The market has witnessed steady growth in the past few years, and the development in technology with the introduction of advanced products has increased the acceptance of Neurodiagnostics products in the market. The market is fueled by the growing adoption of novel diagnostics technologies, upsurge in the number of patients with neurological diseases, and increasing aging population.
Imaging and in vitro diagnostics are the most widely used technologies for the diagnosis of mental health disorders. This particular field is getting revolutionized with the advancement in technology. Globally, there are around dozens of 7-T machines in research labs, and the first 7-T model was cleared for clinical use in 2018. Vendors are focusing on new product launches and targeting toward end user's perspective. The revenue is generated from the key players operating in this field, and few of them include GE Healthcare, Philips Healthcare, Siemens Healthineers, Canon Medical Systems Corporation, Hitachi Medical Corporation, and Nihon Kohden Corporation.
According to Infoholic Research analysis, North America accounted for the largest share of the Global Neurodiagnostics Market in 2018 and will retain a high position during the forecast period. The region has the highest percentage of the geriatric population with a growing prevalence of neural diseases such as Parkinson disease, epilepsy, migraine, and stroke. Further, the availability of advanced technologies is driving the market growth in North America. The Asia Pacific region is expected to witness the fastest growth rate due to the increasing patient pool, growing awareness among patients, and rising healthcare expenditure.
Neurodiagnostics Market by Technology
- Neuroimaging Technologies
- Computed Tomography (CT)
- Nuclear Medicine Imaging (NMI)
- Magnetic Resonance Imaging (MRI)
- Electroencephalography (EEG)
- Magnetoencephalography (MEG)
- Near-infrared Spectroscopic Imaging (NIRS)
- Voxel-based Morphometry (VBM)
- In Vitro Diagnostics
In 2018, the Neuroimaging Technologies segment occupied the largest share and is expected to remain the same during the forecast period. Among various neuroimaging technologies, CT and MRI are the two key imaging modalities commonly used to identify brain anomalies. The neuroinformatics segment is anticipated to grow at a high CAGR during the forecast period.
Neurodiagnostics Market by Regions
- North America
The market is dominated by North America, followed by Europe and Asia Pacific. The US occupied the dominant share in North America due to the rapid adoption of new and advanced diagnostic technologies.
Neurodiagnostics Market Research Competitive Analysis
The Global Neurodiagnostics Market has massive growth opportunities in both developed and developing regions. The advancements and upgradation of technology will increase the competition among vendors. Many vendors are focusing on developing innovative products to strengthen their product portfolio that intensifies the market competition. In January 2018, Brain Vision Solutions launched LiveAmp 64, a high-density wireless EEG solution that can be used with a wide range of innovative electrode technologies and also, there is an easy upgrade path all the way from 8 to 64 channels. Nihon Kohden launched its airEEG WEE-1200 wireless EEG system in March 2018, and it is designed specifically for patient comfort and easy access to real-time patient data during long-term epilepsy monitoring.
GE Healthcare introduced its range of MRI contrast media products with the launch of macrocyclic agent Clariscan in Europe in March 2017. Canon Medical Systems launched its next-generation 80-row multi-slice CT scanner, Aquilion Prime SP, at UKRC in 2017. The company has also initiated collaborative research in March 2018 on the application of Artificial Intelligence (AI)-based technology in MR imaging, together with Kumamoto University and the University of Bordeaux. In addition, other leading players are focusing on investing heavily in R&D activities to develop new products to attain a maximum share in the market.
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- Canon Medical Systems Corporation
- Hitachi Medical Corporation
- Nihon Kohden Corporation
- Fonar Corporation
- Neusoft Medical Systems Co., Ltd.
- NeuroNexus Technologies, Inc.
- Lifelines Neurodiagnostic Systems, Inc.
- NeuroDx Development
- Bruker Corporation
- Plexon Inc
- Natus Medical Incorporated
Key competitive facts
- The market is highly competitive with all the players competing to gain market shares. Intense competition, rapid advancements in technology, frequent changes in government policies, and the prices are key factors that confront the market.
- The requirement of high initial investment, implementation, and maintenance cost in the market are also limiting the entry of new players.
The report provides complete details about the usage and adoption rate of neurodiagnostics products. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the diagnostics segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.
- Understanding the potential market opportunity with precise market size and forecast data.
- A detailed market analysis focusing on the growth of the neurodiagnostics industry.
- Factors influencing the growth of the neurodiagnostics market.
- In-depth competitive analysis of dominant and pure-play vendors.
- Prediction analysis of the neurodiagnostics industry in both developed and developing regions.
- Key insights related to major segments of the neurodiagnostics
- The latest market trend analysis impacting the buying behavior of the consumers.
1 Industry Outlook
1.1 Industry Overview
1.2 Total Addressable Market
1.3 Industry Trends
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition – Infoholic Research
3.2 Types of Neurological Diseases
3.3 Causes of Neurological Diseases
3.4 Signs of Neurological Disorders
3.5 Distinctive Neurological Procedures
3.6 Segmented Addressable Market
3.7 Key Trends in the Neurodiagnostics Market
3.8 Related Markets
3.8.1 Parkinson’s Diseases
3.8.2 Neurointerventional Devices
3.8.3 Neurosurgical Devices
4 Market Outlook
4.1 Market Segmentation
4.2 PEST Analysis
4.3 Porter 5(Five) Forces
5 Market Characteristics
5.1 DRO Analysis – Market Dynamics
22.214.171.124 Increasing number of patients with neurological diseases
126.96.36.199 Increasing aging population
188.8.131.52 Growing adoption of novel diagnostic technologies
184.108.40.206 Upsurge in the introduction of new products and recent product approvals
220.127.116.11 Advancement in technology
18.104.22.168 High cost of diagnosis
22.214.171.124 Lack of trained professionals
5.2 DRO – Impact Analysis
5.3 Key Stakeholders
6 Technologies: Market Size and Analysis
6.2.1 Computed Tomography
6.2.2 Magnetic Resonance Imaging
6.2.3 Nuclear Medicine Imaging
6.2.4 Near Infrared Spectroscopic Imaging
6.2.7 Voxel-based Morphometry
6.3 In Vitro Diagnostics
7 Regions: Market Size and Analysis
7.2 North America
7.4 Asia Pacific
7.5 Rest of the World
8 Competitive Landscape
9 Vendors Profile
9.1 GE Healthcare
9.1.2 Business Units
9.1.3 Geographic Presence
9.1.4 Business Focus
9.1.5 SWOT Analysis
9.1.6 Business Strategies
9.2 Hitachi Medical Corporation
9.2.2 Business Units
9.2.3 Geographic Presence
9.2.4 Business Focus
9.2.5 SWOT Analysis
9.2.6 Business Strategies
9.3 Siemens Healthineers
9.3.2 Business Units
9.3.3 Geographic Presence
9.3.4 Business Focus
9.3.5 SWOT Analysis
9.3.6 Business Strategies
9.4 Philips Healthcare
9.4.2 Business Units
9.4.3 Geographic Presence
9.4.4 Business Focus
9.4.5 SWOT Analysis
9.4.6 Business Strategies
9.5 Canon Medical Systems Corp.
9.5.2 Business Units
9.5.3 Geographic Presence
9.5.4 Business Focus
9.5.5 SWOT Analysis
9.5.6 Business Strategies
9.6 Nihon Kohden Corporation
9.6.2 Business Units
9.6.3 Geographic Presence
9.6.4 Business Focus
9.6.5 SWOT Analysis
9.6.6 Business Strategies
10 Companies to Watch For
10.1 Bruker Corporation
10.1.2 Recent Developments
10.2 Fonar Corporation
10.2.2 Recent Developments
10.3 NeuroNexus Technologies
10.3.2 Recent Developments
10.4 Neusoft Medical Systems Co. Ltd.
10.4.2 Recent Developments
10.5 Plexon Inc.
10.5.2 Recent Developments
10.6 Lifelines Neurodiagnostics Systems Inc.
10.6.2 Recent Developments
10.7 Natus Medical
10.7.2 Recent Developments
10.8 NeuroDx Development
10.8.2 Recent Developments
TABLE 1 CLINICAL TRIALS OF NEUROINTERVENTIONAL DEVICES 22
TABLE 2 GLOBAL NEUROINFORMATICS MARKET REVENUE BY REGIONS, 2018–2025 ($MILLION) 47
TABLE 3 OTHER PROMINENT VENDORS OF NEURODIAGNOSTICS MARKET 55
TABLE 4 GE HEALTHCARE: OFFERINGS 57
TABLE 5 GE HEALTHCARE: RECENT DEVELOPMENTS 58
TABLE 6 HITACHI MEDICAL CORPORATION: OFFERINGS 65
TABLE 7 HITACHI MEDICAL CORPORATION: RECENT DEVELOPMENTS 66
TABLE 8 SIEMENS HEALTHINEERS: PRODUCT OFFERINGS 71
TABLE 9 SIEMENS HEALTHINEERS: RECENT DEVELOPMENTS 72
TABLE 10 PHILIPS HEALTHCARE: PRODUCT OFFERINGS 78
TABLE 11 PHILIPS HEALTHCARE: RECENT DEVELOPMENTS 79
TABLE 12 CANON MEDICAL SYSTEMS CORP.: PRODUCT OFFERINGS 86
TABLE 13 CANON MEDICAL SYSTEMS CORP.: RECENT DEVELOPMENTS 86
TABLE 14 NIHON KOHDEN CORPORATION.: PRODUCT OFFERINGS 92
TABLE 15 NIHON KOHDEN CORPORATION: RECENT DEVELOPMENTS 92
TABLE 16 BRUKER CORPORATION: SNAPSHOT 99
TABLE 17 FONAR CORPORATION: SNAPSHOT 101
TABLE 18 NEURONEXUS TECHNOLOGIES: SNAPSHOT 102
TABLE 19 NEUSOFT MEDICAL SYSTEMS CO., LTD.: SNAPSHOT 103
TABLE 20 PLEXON INC.: SNAPSHOT 104
TABLE 21 LIFELINES NEURODIAGNOSTICS SYSTEMS, INC.: SNAPSHOT 105
TABLE 22 NATUS MEDICAL: SNAPSHOT 106
TABLE 23 NEURODX DEVELOPMENT: SNAPSHOT 107
Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
Market related information is congregated from both primary and secondary sources.
Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.